Recurrent embolic stroke on treatment
Evidence-based neurology checklist on recurrent embolic stroke on treatment: Frequency This occurs in about 15% of anticoagulated people with atrial fibrillation (AF) The annual risk is 3.2 - 6.5% per year Neurological risk factors Cardiac risk factors Systemic risk factors Management
Frequency
- This occurs in about 15% of anticoagulated people with atrial fibrillation (AF)
- The annual risk is 3.2 - 6.5% per year
Neurological risk factors
Cardiac risk factors
Systemic risk factors
Management
References
- McCabe JJ, Cheung Y, Foley M, et al. Residual risk of recurrent stroke despite anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis. JAMA Neurol 2025 (Online ahead of print).
- Cheung Y, Foley M, Bradley D, et al. Clinical and biomarker determinants for recurrent stroke in patients with atrial fibrillation: a systematic review and meta-analysis. Neurology 2025; 104:e210061.
- Broukhim M, Halperin JL. Stroke prevention in the high-risk atrial fibrillation patient: medical management. Curr Cardiol Rep 2011; 13:9-17.
- Chan PH, Huang D, Hai JJ, et al. Stroke prevention using dabigatran in elderly Chinese patients with atrial fibrillation. Heart Rhythm 2016; 13:366-373.
- Masjuan J, Salido L, DeFelipe A, et al. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke. Eur J Neurol 2019; 26:816-820.
- And 2 more. Subscribe to see the full list
